申请人:Bayer Corporation
公开号:US05932763A1
公开(公告)日:1999-08-03
The present invention provides pharmaceutical compositions and methods for treating certain conditions comprising administering an amount of a compound or composition of the invention which is effective to inhibit the activity of at least one matrix metalloprotease, resulting in achievement of the desired effect. The compounds of the present invention are of the generalized formula ##STR1## where v is 1, 2, 3 or 4 and Ar represents a substituted aromatic moiety. These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibular joint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from atherosclerotic plaque rupture. The present invention also provides pharmaceutical compositions and methods for treating such conditions.
本发明提供了制药组合物和治疗某些疾病的方法,包括给予本发明的化合物或组合物的有效剂量,以抑制至少一种基质金属蛋白酶的活性,从而达到所需的效果。本发明的化合物属于广义公式## STR1## 中,其中v为1、2、3或4,Ar代表取代芳香基团。这些化合物对于抑制基质金属蛋白酶是有用的,因此可以对抗MMP对其有贡献的疾病,例如骨关节炎、类风湿性关节炎、败血性关节炎、牙周疾病、角膜溃疡、蛋白尿、动脉瘤性主动脉疾病、营养不良性表皮松解性水疱病、导致炎症反应的疾病、MMP活性介导的骨质疏松症、颞下颌关节疾病、神经系统脱髓鞘性疾病、肿瘤转移或创伤性关节损伤后的退化性软骨丢失以及冠状动脉血栓形成的斑块破裂。本发明还提供了用于治疗这些疾病的制药组合物和方法。